Comparison of long-term outcomes of infliximab and adalimumab therapy in biologic-naive patients with ulcerative colitis

Background: To compare the long-term safety and efficacy of Adalimumab (ADA) and Infliximab (IFX) agents in biologic-naive patients with Ulcerative colitis (UC). Methods: The key focus was on specific outcomes such as the requirement of hospitalization due to UC, colectomy, steroid administration, a...

Full description

Bibliographic Details
Published in:The Saudi Journal of Gastroenterology
Main Authors: Muhammed B. Durak, Yavuz Cagir, Ilhami Yuksel
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Subjects:
adalimumab
colectomy
infliximab
ulcerative colitis
Online Access:https://journals.lww.com/10.4103/sjg.sjg_180_24

Internet

https://journals.lww.com/10.4103/sjg.sjg_180_24

Similar Items